You have 9 free searches left this month | for more free features.

Advanced solid tumor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor Trial (HR19024)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jul 18, 2022

Advanced Solid Tumor Trial (HS-IT101)

Not yet recruiting
  • Advanced Solid Tumor
  • HS-IT101
  • (no location specified)
Sep 12, 2022

Advanced Solid Tumor Trial in Shanghai (SY-4798)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai East Hospital
Aug 10, 2022

Advanced Solid Tumor Trial (Linperlisib Tablet)

Not yet recruiting
  • Advanced Solid Tumor
  • Linperlisib Tablet
  • (no location specified)
Jun 20, 2022

Advanced Solid Tumor Trial in Tianjin (SHR-1802+camrelizumab + famitinib)

Recruiting
  • Advanced Solid Tumor
  • SHR-1802+camrelizumab + famitinib
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute&Hospital
May 25, 2022

Metastatic Solid Tumor, Advanced Solid Tumor Trial (XT-0528)

Not yet recruiting
  • Metastatic Solid Tumor
  • Advanced Solid Tumor
  • (no location specified)
Jul 22, 2022

Advanced Solid Tumor Trial (SGN1)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Aug 11, 2022

Advanced Solid Tumor Trial (Utidelone Capsule)

Not yet recruiting
  • Advanced Solid Tumor
  • Utidelone Capsule
  • (no location specified)
Jan 10, 2023

Solid Tumor Trial in Nedlands (MAX-10181)

Recruiting
  • Solid Tumor
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Jan 18, 2022

Solid Tumor Trial in Hangzhou (WBC100)

Recruiting
  • Solid Tumor
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 13, 2022

Solid Tumor Trial in Yantai (NK combined with Chemotherapy, Chemotherapy)

Recruiting
  • Solid Tumor
  • Yantai, Shandong, China
    Yantai Yuhuangding Hospital
Feb 7, 2022

Solid Tumor Trial in Hangzhou (MAX-10181)

Recruiting
  • Solid Tumor
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 18, 2022

Solid Tumor Trial in Shanghai (Camrelizumab, Famitinib)

Active, not recruiting
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Zhongshan Hospital
Feb 9, 2022

Advanced Solid Tumor Trial in Shanghai (FCN-011)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 16, 2021

Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • (no location specified)
Jan 28, 2023

Solid Tumor Trial in Yantai (DC-CIK combined with Chemotherapy, Chemotherapy)

Recruiting
  • Solid Tumor
  • Yantai, Shandong, China
    Yantai Yuhuangding Hospital
Feb 7, 2022

Advanced Solid Tumor Trial in Shanghai (SY-4835)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Renji Hospital Affiliated to Shanghai Jiaotong University School
Mar 11, 2022

Advanced Solid Tumor Trial in Brisbane (AMT-116)

Not yet recruiting
  • Advanced Solid Tumor
  • Brisbane, Queensland, Australia
    ICON Cancer Centre
Feb 2, 2023

Advanced Solid Tumor Trial (TR128)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Feb 20, 2023

Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)

Not yet recruiting
  • Advanced Solid Tumor
  • Oncolytic Virus Injection(Revottack)+PD-1
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022

Advanced Solid Tumor Trial in Shijiazhuang (Camrelizumab/sintilimab+ Standard chemo, Camrelizumab/sintilimab+

Recruiting
  • Advanced Solid Tumor
  • Camrelizumab/sintilimab+ Standard chemotherapy
  • +2 more
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Dec 8, 2021

Solid Tumor Trial in Jinan (IBI325 + sintilimab, IBI325)

Recruiting
  • Solid Tumor
  • Jinan, Shandong, China
    Shandong Province Cancer Hospital
Mar 8, 2022

Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

Not yet recruiting
  • Solid Tumor
  • +4 more
  • (no location specified)
Feb 21, 2023

Solid Tumor, NSCLC, Pancreatic Cancer Trial in China (BPI-442096)

Not yet recruiting
  • Solid Tumor
  • +3 more
  • Guangzhou, Guangdong, China
  • +4 more
Jun 15, 2022